This bill requires a pharmacist who receives a prescription for a specific biological product to select a less expensive interchangeable biological product, unless, in the exercise of his or her professional judgment, the pharmacist believes that the less expensive drug is not suitable for the particular patient. The pharmacist must provide notice to the patient regarding the selection of a less expensive interchangeable biological product.